Genenta Science SpA ADR (GNTA)

NASDAQ
7.75
0.00(0.00%)
  • Volume:
    0
  • Day's Range:
    7.20 - 8.01
  • 52 wk Range:
    5.11 - 13.13

GNTA Overview

Prev. Close
7.94
Day's Range
7.2-8.01
Revenue
-
Open
8
52 wk Range
5.11-13.13
EPS
-0.32
Volume
0
Market Cap
141.14M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
6,100
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
18,216,858
Next Earnings Date
-
What is your sentiment on Genenta Science ADR?
or
Vote to see community's results!

Genenta Science SpA ADR Company Profile

Genenta Science SpA ADR Company Profile

Employees
4

Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company’s lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. It is also developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. The company was incorporated in 2014 and is headquartered in Milan, Italy.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyBuyBuy
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy